Compier L2A Case Management

Home / Innovation / Compier L2A Case Management

Automate EMA E2B R3 File filter process for improved efficiency and compliance

Pharma companies are required to download E2B R3 files from the EV Web portal based on active substances (not based on the company’s products). Due to this regulatory change, Pharmacovigilance operations at small to mid-size companies are challenged with timely completion of review and submission of huge volumes of ICSRs.  It is must for companies to include these ICSRs in the company’s centralized safety database to comply with other regulatory agencies for expedited reporting.

Compier L2A Case Management

Compier L2A Case Management is an E2B R3 File Filter to help companies automate the filtering process and designed specifically to address the efficiency and case volume management related to L2A cases. L2A Case Filter automatically reads the product information from the incoming E2B R3 files and compare it with existing configurations. Compier L2A Case Management module has the capability to compare configurations defined in the drug safety system or with a custom defined list and filter out any files which are not related to the pharma company products. This module is highly configurable and provides a comprehensive activity log for future reference.

Office Desk

Key Product Features

L2A Case Filter provides various, ready to use dashboards and reports to manage the process efficiently.

  • Dashboard for total cases processed in a specific time interval with details of success and non-success numbers
  • Total number of cases received for a country and processed based on report type
  • Multiple trend reports indicating total number of cases reported by time interval, source, product etc

Compier L2A Case Filter directly reduces manual effort and address the regulatory compliance needs of the pharmacovigilance department.

How Do we Deliver

Compier L2A Case Management is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform.

New Insights

Enabling eSource in Clinical Studies to Optimize Trial Quality

Source data is all information in original records and certified copies of original records of clinical findings, observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial. Electronic data source or eSource is the data that is initially recorded in electronic format in this process. Biopharma and MedTech [...]

Implementing Electronic Consent for Clinical Trial Participation

Industry Background of eConsent In an attempt to address health authority concerns and improve patient confidence, companies and independent industry bodies have experimented with electronic consent (eConsent) using electronic media such as smartphones, laptops, and tablets. Despite positive outcomes, its implementation remained experimental until FDA officially released a guidance in December 2016. Following in FDA’s [...]

Top 4 Trial Design Best Practices for Medical Device Clinical Studies

What drives the growing complexity in medical device clinical trials? The medical devices industry has revolutionized medicine with significant advances in both detection and treatment of diseases. Clinical trials for medical device regulatory approval are designed to produce valid scientific evidence of safety and effectiveness for the intended uses. Moreover, sponsors must consider designing trials [...]

Get in Touch with Us